Quantcast

Latest Clinical Laboratory Improvement Amendments Stories

2011-07-27 00:01:19

iGenix today announced it has received CLIA approval for its first diagnostic assay created to run on the Illumina BeadXpress. Seattle, WA (PRWEB) July 26, 2011 iGenix today announced it has received CLIA approval for its first diagnostic assay created to run on the Illumina BeadXpress, a high-throughput genomic analysis platform manufactured by Illumina Inc. The pharmacogenomics assay certified was built as a "proof-of-principle" test for CLIA certification, and is one of several in...

2011-04-26 19:37:00

VICTORIA, Australia, April 26, 2011 /PRNewswire/ -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) has gained certification of its Australian laboratory under the US Clinical Laboratories Improvements Amendments (CLIA) (42 U.S.C. section 263a) regulated by the Centers for Medicare and Medicaid (CMS). The certification was issued by the CMS central office which is responsible for approving non-US laboratories. This certification is the culmination of preparations required for the...

2011-04-20 07:10:00

TEMPE, Ariz., April 20, 2011 /PRNewswire/ -- Intrinsic Bioprobes Inc. ("IBI") today announced the launch of its first mass spectrometry-based protein assays for in-vitro diagnostic testing. The assays for beta-2-microglobulin, cystatin C, and retinol binding protein are performed on IBI's MASSAY® platform at the CLIA-certified and College of American Pathology (CAP) accredited diagnostic laboratory of the Institute of Genomics Medicine, UMDNJ-New Jersey Medical School....

2011-04-11 05:32:00

MILTON PARK, OXFORD, England and SAN DIEGO, April 11, 2011 /PRNewswire/ -- Enigma Diagnostics announced today that it has commenced clinical trials for its intended point of care Enigma® ML Influenza A/B detection assay. Enigma will submit its application to the U.S. Food and Drug Administration (FDA) for approval of the assay in 2012. The Enigma® ML instrument platform combines fully-automated sample extraction with real-time PCR amplification and...

2011-03-30 02:00:00

CRAIGAVON, Northern Ireland, March 30, 2011 /PRNewswire/ -- Almac's Diagnostics business unit today announced the opening of its CLIA registered laboratory. The opening of the Almac CLIA Laboratory supports the company's ongoing Biomarker Discovery and Development Strategy by enabling the use of novel tests to stratify and enrich prospective clinical trails. This ability is of key importance as Almac begins to transition the novel biomarkers that they have developed into clinical...

2011-03-15 08:00:00

CENTENNIAL, Colo. and ALISO VIEJO, Calif., March 15, 2011 /PRNewswire/ -- LABS, Inc., the recognized leader in microbiology, infectious disease screening, cell/molecular biology and immunological testing for the transplant and biomedical sciences communities, today announced an agreement with Ambry Genetics, a global leader in molecular diagnostics and genomic services to the healthcare and life sciences industries, that will allow the organizations to provide superior testing services to a...

2011-03-07 07:30:00

ANN ARBOR, Mich. March 7, 2011 /PRNewswire/ -- Everist Genomics announced today that it has received U.S. Clinical Laboratory Improvement Amendment (CLIA) certification required for the company to launch its OncoDefender-CRC assay, a prognostic test for assessing the risk of cancer recurrence for patients with early stage colorectal cancer. Because OncoDefender-CRC is categorized by CLIA as a high complexity test, it is evaluated against the most stringent federally-mandated requirements,...

2011-02-19 06:00:00

LENEXA, Kan., Feb. 19, 2011 /PRNewswire/ -- CompanDX Ltd., bioinformatics partner for the life sciences industry, and Clinical Reference Laboratory, Inc. (CRL), provider of laboratory testing services in molecular diagnostics and clinical trials, today announced they entered into a multi-year agreement to collaborate in the development and support of biomarker panels and companion diagnostic development for pharmaceutical, biotech and academic clients worldwide. Under the terms of the...

2011-01-11 09:17:00

HOUSTON, Jan. 11, 2011 /PRNewswire/ -- SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, continues to make significant strides to position itself as the Next-Generation Sequencing Provider of choice for 2011. SeqWright's ongoing success can be attributed to the company's ability to respond quickly to customer's demands and by investing in key genomics technologies. Building on this success, SeqWright announced today the expansion of its Next-Generation...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related